Literature DB >> 23222547

The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma.

Junji Yamashita1, Takuma Iwakiri, Satoshi Fukushima, Masatoshi Jinnin, Azusa Miyashita, Takeshi Hamasaki, Takamitsu Makino, Jun Aoi, Shinichi Masuguchi, Yuji Inoue, Hironobu Ihn.   

Abstract

MicroRNA-146a (miR-146a) is one of the microRNAs (miRNAs) implicated in the pathogenesis of various cancers. Recently, single nucleotide polymorphisms (SNPs) located in miRNAs themselves, so-called MIRSNPs, have attracted attention because of their possible involvement in the pathogenesis of various diseases. Such MIRSNPs may play functional roles because of the alteration of the miRNA. In this study, we investigated whether MIRSNP rs2910164 in miR-146a is involved in the pathogenesis of malignant melanoma (MM). DNA samples were collected from 50 patients with MM and 107 controls and genotyped by a PCR-restriction fragment. In patients with MM, the genotype distributions were 15 CC (30.0%), 35 CG (70.0%), and 0 GG (0.0%). The CG genotype was significantly increased in the patients compared with the controls (P=0.02). The minimum free energy between miR-146a and its complementary strand with the G allele was determined to be -26.8 kcal/mol, whereas that of the C allele was -24.0 kcal/mol, indicating that the change from C to G may increase the stability of the miR-146a. However, there was no significant difference between the CC and the CG genotypes in terms of the relative expression levels of miR-146a. Human melanoma cell lines with the G allele showed significantly higher proliferation, migration, and invasion than those with the C allele. In conclusion, miR-146a may be involved in the pathogenesis of MM, and individuals with the CG genotype have an increased risk of developing MM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23222547     DOI: 10.1097/CMR.0b013e32835c5b30

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  13 in total

1.  Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.

Authors:  D Wan; W Gu; G Xu; C Shen; D Ding; S Shen; S Wang; X Gong; S He; Q Zhi
Journal:  Clin Transl Oncol       Date:  2014-01-08       Impact factor: 3.405

Review 2.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 3.  MicroRNA heterogeneity in melanoma progression.

Authors:  Anita Thyagarajan; Kenneth Y Tsai; Ravi P Sahu
Journal:  Semin Cancer Biol       Date:  2019-06-01       Impact factor: 15.707

Review 4.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

Review 5.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

6.  Association between ankylosing spondylitis and the miR-146a and miR-499 polymorphisms.

Authors:  Hui Ying Xu; Zhang Yang Wang; Jing Feng Chen; Tian Yang Wang; Ling Ling Wang; Li Li Tang; Xian-yang Lin; Chun-wu Zhang; Bi-cheng Chen
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

7.  MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches.

Authors:  Joseph Markowitz; Zachary Abrams; Naduparambil K Jacob; Xiaoli Zhang; John N Hassani; Nicholas Latchana; Lai Wei; Kelly E Regan; Taylor R Brooks; Sarvani R Uppati; Kala M Levine; Tanios Bekaii-Saab; Kari L Kendra; Gregory B Lesinski; J Harrison Howard; Thomas Olencki; Philip R Payne; William E Carson
Journal:  Onco Targets Ther       Date:  2016-09-29       Impact factor: 4.147

8.  A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.

Authors:  Lili Cui; You Li; Guoda Ma; Yan Wang; Yujie Cai; Shengyuan Liu; Yanyan Chen; Jia Li; Yuliu Xie; Gen Liu; Bin Zhao; Keshen Li
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

9.  miR-146a promotes the initiation and progression of melanoma by activating Notch signaling.

Authors:  Matteo Forloni; Shaillay Kumar Dogra; Yuying Dong; Darryl Conte; Jianhong Ou; Lihua Julie Zhu; April Deng; Meera Mahalingam; Michael R Green; Narendra Wajapeyee
Journal:  Elife       Date:  2014-02-18       Impact factor: 8.140

10.  Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies.

Authors:  Xiao Pin Ma; Ting Zhang; Bo Peng; Long Yu; De Ke Jiang
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.